Abstract:In bioinformatics, machine learning-based prediction of drug-target interaction (DTI) plays an important role in virtual screening of drug discovery. DTI prediction, which have been treated as a binary classification problem, depends on the concentration of two molecules, the interaction between two molecules, and other factors. The degree of affinity between a drug molecule (such as a drug compound) and a target molecule (such as a receptor or protein kinase) reflects how tightly the drug binds to a particular target and is quantified by the measurement which can reflect more detailed and specific information than binary relationship. In this study, we proposed an end-to-end model, named AttentionDTA, based on deep learning, which associates attention mechanism to predict the binding affinity of DTI. The novelty in this work is to use attentional mechanisms to consider which subsequences in a protein are more important for a drug and which subsequences in a drug are more important for a protein when predicting its affinity. So that the representational ability of the model is stronger. The model uses one-dimensional Convolution Neural Networks (1D-CNNs) to extract the abstract information of drug and protein, and makes the drug and protein representations mutually adapt through the attention mechanisms. We evaluate our model on two established drug-target affinity benchmark datasets, Davis and KIBA. The model outperforms DeepDTA, a state-of-the-art deep learning method for drug–target binding affinity prediction, with better Mean Squared Error (MSE), Concordance Index (CI), $r_{m}^{2}$, and Area Under Precision Recall Curve (AUPR). Our results show that the attention-based model can effectively extract effective representations by calculating the weight of the representation between the drug and the protein. Finally, we visualize the attention weight. It proves our model can obtain the information of binding sites.

LSTM-SAGDTA: Predicting Drug-Target Binding Affinity with an Attention Graph Neural Network and LSTM Approach

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

Prediction of Drug-Target Affinity Using Attention Neural Network

GLSTM-DTA: Application of Prediction Improvement Model Based on GNN and LSTM

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM

SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

GDGRU-DTA: Predicting Drug-Target Binding Affinity Based on GNN and Double GRU

MTAF–DTA: multi-type attention fusion network for drug–target affinity prediction

GTAMP-DTA: Graph transformer combined with attention mechanism for drug-target binding affinity prediction

SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction

AttentionDTA: prediction of drug–target binding affinity using attention model

NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

Drug-target binding affinity prediction using message passing neural network and self supervised learning

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections

MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction

GraphDTA: predicting drug-target binding affinity with graph neural networks